Arrhythmias in Fabry Cardiomyopathy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Cardiology

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/clc.22047PMID 22886820PMCID PMC6652687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The heart in Fabry's disease.

  2011cited by this paper
• Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.

  2011cited by this paper
• Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease.

  2011cited by this paper
• The Fabry cardiomyopathy: models for the cardiologist.

  2011cited by this paper
• Cardiovascular events in patients with fabry disease natural history data from the fabry registry.

  2010cited by this paper
• Fabry Disease: Cardiac Manifestations and Therapeutic Options

  2009cited by this paper
• Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.

  2008cited by this paper
• Terminal stage cardiac findings in patients with cardiac Fabry disease : an electrocardiographic, echocardiographic, and autopsy study

  2008cited by this paper
• Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

  2007cited by this paper
• Images in cardiovascular medicine. Cryptogenic ventricular arrhythmias and sudden death by Fabry disease: prominent infiltration of cardiac conduction tissue.

  2007cited by this paper
• Cryptogenic Ventricular Arrhythmias and Sudden Death by Fabry Disease: Prominent Infiltration of Cardiac Conduction Tissue

  2007cited by this paper
• Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

  2007cited by this paper
• 76: Congestive heart failure in Fabry cardiomyopathy: Natural history experience in an international cohort of 1,448 patients

  2006cited by this paper
• Natural history of Fabry disease

  2006cited by this paper
• Natural history and effects of enzyme replacement therapy in children and adolescents with Fabry disease -- Fabry Disease: Perspectives from 5 Years of FOS

  2006cited by this paper
• The heart in Fabry disease

  2006cited by this paper
• Fabry Disease: Percutaneous Transluminal Septal Myocardial Ablation Markedly Improved Symptomatic Left Ventricular Hypertrophy and Outflow Tract Obstruction in a Classically Affected Male

  2005cited by this paper
• Ventricular Tachycardias and Dilated Cardiomyopathy Caused by Fabry Disease

  2005cited by this paper
• Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease.

  2005cited by this paper
• [Fabry disease--a diagnostic and therapeutic challenge].

  2005cited by this paper
• The molecular defect leading to Fabry disease: structure of human alpha-galactosidase.

  2004cited by this paper
• Enzyme replacement therapy with agalsidase β improves cardiac involvement in Fabry's disease

  2004cited by this paper
• Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry Disease: A Prospective Strain Rate Imaging Study

  2003cited by this paper
• [Cardiac manifestations of Fabry disease].

  2003cited by this paper
• Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

  2001cited by this paper
• Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

  2001cited by this paper
• Cardiac manifestations in Fabry disease

  2001cited by this paper
• Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy.

  2001cited by this paper
• Prevalence of lysosomal storage disorders.

  1999cited by this paper
• Fabry's disease with complete atrioventricular block: histological evidence of involvement of the conduction system

  1992cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

  1986cited by this paper

• Anderson–Fabry Disease: An Overview of Current Diagnosis, Arrhythmic Risk Stratification, and Therapeutic Strategies

  2025cites this paper
• Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction

  2025cites this paper
• Non‐Pulmonary Vein Substrate Ablation of Recurrent Atrial Fibrillation in the Patient With Fabry Disease

  2025cites this paper
• Ventricular arrhythmias and primary prevention of sudden cardiac death in Anderson-Fabry disease.

  2024cites this paper
• Arrhythmogenesis in Fabry Disease

  2024influential citation
• Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease

  2023cites this paper
• Ambulatory electrocardiographic monitoring in patients with Fabry disease: study design and cohort characterization

  2023cites this paper
• Transcatheter Tricuspid Valve Replacement for Anderson Fabry Disease With Severe Tricuspid Regurgitation

  2022cites this paper
• Arrhythmias in Chronic Kidney Disease

  2022cites this paper
• Fabry Disease and the Heart: A Comprehensive Review

  2021cites this paper
• Radiofrequency ablation of ventricular tachycardia in Anderson–Fabry disease: a case series

  2021cites this paper
• Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotype.

  2020cites this paper
• An expert consensus document on the management of cardiovascular manifestations of Fabry disease

  2020cites this paper
• COVID-19 and Heart: From Clinical Features to Pharmacological Implications

  2020cites this paper
• The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects

  2020cites this paper
• Genotype–Phenotype Correlation in a New Fabry-Disease-Causing Mutation

  2019cites this paper
• Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy

  2019influential citation
• European expert consensus statement on therapeutic goals in Fabry disease.

  2018cites this paper
• Screening, diagnosis, and management of patients with Fabry disease: conclusions from a ``Kidney Disease: Improving Global Outcomes'' (KDIGO) Controversies Conference

  2018cites this paper
• Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice

  2018cites this paper
• Awareness of Fabry disease in cardiology: A gap to be filled.

  2018cites this paper
• Neurometabolic Hereditary Diseases of Adults

  2018cites this paper
• Anderson-Fabry disease in heart failure

  2018cites this paper
• Myocardial infarction in Fabry disease – misfortune or companion? Case report and review of the literature (RCD code: III‑3B.2)

  2018cites this paper
• 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2017cites this paper
• Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

  2017cites this paper
• 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2017cites this paper
• 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2017cites this paper
• Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy.

  2017cites this paper
• 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2017cites this paper
• Arrhythmia and Clinical Cardiac Findings in Children With Anderson-Fabry Disease.

  2017cites this paper
• Cardiac device implantation in Fabry disease

  2016cites this paper
• Inherited Structural Heart Diseases With Potential Atrial Fibrillation Occurrence

  2016cites this paper
• The Central Nervous System Involvement in Fabry Disease: A Review

  2016cites this paper
• Ventricular Tachycardia in Fabry Disease Detected in a 50-Year-Old Woman during 14-Day Continuous Cardiac Monitoring.

  2016cites this paper
• The Central Nervous System Involvement in Fabry Disease

  2016cites this paper
• Electrocardiographic Changes and Arrhythmia in Fabry Disease

  2016cites this paper
• Arrhythmias in Fabry cardiomyopathy.

  2015cites this paper
• Fabry cardiomyopathy is a multisystem disorder with important cardiovascular involvement. Arrhythmias can cause significant morbidity and mortality in Fabry disease. Fabry disease can be diagnosed by measurement of plasma a-galactosidase A or mutation

  2015cites this paper
• Fabry cardiomyopathy presenting with a high defibrillation threshold: A short case report

  2015cites this paper
• Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment

  2015cites this paper
• Atrial Tachycardia in a Patient With Fabry’s Disease

  2015cites this paper
• Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases

  2014cites this paper
• Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.

  2014cites this paper
• Increased Arterial Diameters in the Posterior Cerebral Circulation in Men with Fabry Disease

  2014cites this paper
• A mutant mRNA expression in an endomyocardial biopsy sample obtained from a patient with a cardiac variant of Fabry disease caused by a novel acceptor splice site mutation in the invariant AG of intron 5 of the α-galactosidase A gene.

  2013cites this paper
• transplantation Chronic kidney disease : including end-stage renal disease requiring renal replacement therapy with dialysis or renal transplantation Stroke or transient ischemic attacks Deafness , of acute or chronic onset R Schiffmann

  year unknowncites this paper